Clinical Trials - Key findings Type 2 diabetes (40 weeks): HbA1c 1.241.48% (vs 0.41% placebo) Weight loss 4.57.6% (vs 1.7% placebo) Obesity without diabetes (72 weeks): Mean weight loss 11.2% 54.6% achieved 10% weight loss Improved cardiometabolic markers Efficacy similar to semaglutide/liraglutide (slightly less than tirzepatide) Safety: GI effects most common (during dose escalation) Low discontinuation rates No major hypoglycemia, hepatic, or CV safety signals so far Orforglipron combines oral convenience + GLP-1level efficacy, with the potential to improve access, adherence, and long-term outcomes in diabetes and obesity management
Research Citations Huang, Y.-N., Chen, J.-C., Li, P.-H., Hsu, M.-Y., Cheng, C.-W., Meyerowitz-Katz, G., & Su, P.-H
Your online privacy is a top priority for us, so you can shop with confidence knowing your sensitive information is safe when purchasing TrimRx GLP-1 from us.
Asking about lifestyle habits also helps to ensure the medication fits into the patients health journey
Notes and Considerations Research: It can be hard to imagine that seemingly reputable websites would sell an ineffective product, however research should be done before making a purchase as many vendors will offer products that are inferior or outright falsely labeled as MT II peptide
